Condition: Heavy Menstrual Bleeding · Bleeding Disorder · Von Willebrand Diseases · Sponsor: Oregon Health and Science University
The goal of this multicenter prospective observational study and registry of U.S. adolescents and young adults with heritable bleeding disorders is to determine the bleeding outcomes, satisfaction, hemostatic parameter changes, and patient reported quality of life after 6 months of use of either of two commonly used hormonal treatments for menstrual suppression - levonorgestrel intrauterine device (LNG-IUD) and norethindrone acetate (NETA). Under this application the study will compare the two treatments and compare outcomes after LNG-IUD treatment results to a control group without a bleeding disorder, with the goal of determining the benefits and expected outcomes of these treatment options for this population.
This description comes directly from the study's public registry record.
OHSU Women's Health Research Unit · 5034943666 · whru@ohsu.edu
Maureen Baldwin, MD MPH · 5034949762 · schaum@ohsu.edu
Always discuss trial participation with your own doctor first.
| Stanford | Palo Alto, California, United States | Not Yet Recruiting |
| Colorado Anschutz Medical Campus | Aurora, Colorado, United States | Not Yet Recruiting |
| Emory | Atlanta, Georgia, United States | Not Yet Recruiting |
| University of Michigan Medicine | Ann Arbor, Michigan, United States | Not Yet Recruiting |
| Children's Mercy | Kansas City, Missouri, United States | Not Yet Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
| Penn State Health | Hershey, Pennsylvania, United States | Not Yet Recruiting |
| University of Washington | Seattle, Washington, United States | Not Yet Recruiting |
| Seattle Children's Hospital | Seattle, Washington, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05916469